mjewkes | 3 years ago | on: High cost of cancer care in the U.S. doesn’t reduce mortality rates
mjewkes's comments
mjewkes | 3 years ago | on: High cost of cancer care in the U.S. doesn’t reduce mortality rates
The US is ~35% of the global pharmaceutical industry, which is the topline driver of new drug development.
When the US pays top dollar for new drugs, it does effectively subsidize European access to the new research.
>Do you have any data to backup your claim?
I would suggest https://www.rand.org/pubs/research_briefs/RB9412.html
or the Great American Drug Deal, by Peter Kolchinsky.
mjewkes | 3 years ago | on: High cost of cancer care in the U.S. doesn’t reduce mortality rates
I would suggest The Great American Drug Deal, by Peter Kolchinsky.
Also - https://www.rand.org/pubs/research_briefs/RB9412.html
>For example Cuban healthcare/treatment/outcome is excellent based on its own research
Cuba does not contribute substantially to global pharmaceutical research.
>Roche(Swiss) nor Merck ( German, not related to US Merck) don't benefit much (if at all) from US subsidies.
Roche makes 55% of its revenue from US drug sales (https://assets.cwp.roche.com/f/126832/x/db9d31e8a7/fb20e.pdf p22)
EMD Serono (formerly Merck KgAA) is similar.
These revenues are the topline driver of the drug development industry.
mjewkes | 4 years ago | on: OpenTTD 12.0-RC1
It seems like there are so many features like CargoDist/FIRS/City growth - many of which are "essential", but don't play well together, or have questionable balance.
mjewkes | 4 years ago | on: Postgres Full-Text Search: A search engine in a database
It returns only results that contain the exact multi word sequence in exactly the same order.
mjewkes | 4 years ago | on: Postgres Full-Text Search: A search engine in a database
Whether or not it works in your specific situation depends on your use case.
mjewkes | 4 years ago | on: Postgres Full-Text Search: A search engine in a database
Looks like we get 37 results, of which 2 are true positives.
Looks like "your" and "own" are both contained in the english.stop stopwords list. So you could fix this by removing stopwords from your dictionary.
While disabling the stemmer is relatively easy (use the 'simple' language setting for your ts_query), altering the stopword dictionaries is more involved, and not easy to maintain or pass between developers/environments, and not at all easy to share between queries.
And so the most common suggestion is to use ILIKE.
Lucene has no problems with any of this.
mjewkes | 4 years ago | on: Postgres Full-Text Search: A search engine in a database
mjewkes | 5 years ago | on: Suppressing a gene by using its antibody can lead to tooth growth: animal study
mjewkes | 5 years ago | on: Why did renewables become so cheap so fast?
I'm assuming you're referring to Ferroni and Hopkirk (2016) which claimed ERORI of ~0.8-1.7.
You should be aware that their work has been pretty thoroughly picked apart - the rebuttal produced immediately after the above, by 27 international scholars, suggests a ERORI of 7-8. It has likely improved since that time.
https://www.sciencedirect.com/science/article/pii/S030142151...
mjewkes | 5 years ago | on: Limits of Current US Prediction Markets (PredictIt Case Study)
They are currently +-0.05$ of PI. A material but not enormous difference
mjewkes | 5 years ago | on: Ask HN: Guild/Studio structure for Software Engineers?
They shipped Dead Cells, which is rated as "Overwhelmingly Positive" "96% of 50,435 reviews" on steam.
https://store.steampowered.com/app/588650/Dead_Cells/
The HaXe programming language originally came out of Motion Twin, although Nicolas Cannasse has since left to do his own thing.
mjewkes | 5 years ago | on: Ask HN: What scientific phenomenon do you wish someone would explain better?
mjewkes | 6 years ago | on: The Doctor Who Helped Defeat Smallpox Explains What's Coming
You didn’t multiply by 100 to change from per unit to per cent.
Still bad though.
mjewkes | 6 years ago | on: Mark Zuckerberg Interviews Patrick Collison and Tyler Cowen
mjewkes | 6 years ago | on: Mark Zuckerberg Interviews Patrick Collison and Tyler Cowen
At the same time, pc, Cowen, and Zuck are in the thick of the SF "conservative libertarian" milieu. Thiel was a/the first major investor in FB, Stripe, and Cowen's "Emergent Ventures". Cowen's Mercatus center has deep ties (that I don't fully understand) with Koch industries and the federalist society. Etc.
I'm _far_ less impressed with the policies actually advocated for by these groups.
I'd actually be really interested in hearing the three of them discuss opportunities for government policy to have significant positive impact. I'd be surprised if pc wasn't a fan of at least some aspects of the FAA / NTSB [3], and I know Cowen advocates for public increases in basic research / R&D investment [4].
As "libertarian conservative" "public thought leaders", I wonder where else they might agree that government intervention can be net very-positive.
[Edit: sorry about the labels. There are real clusters of thinking and people here that need names, but I'm sure that they'd prefer different labels]
[1] https://www.theatlantic.com/science/archive/2019/07/we-need-...
[2] https://www.amazon.com/Stubborn-Attachments-Prosperous-Respo... + thorough review/interview https://80000hours.org/podcast/episodes/tyler-cowen-stubborn...
[3] https://twitter.com/patrickc/status/1021995602970923010
[4] https://marginalrevolution.com/marginalrevolution/2013/02/th...
mjewkes | 6 years ago | on: Open-Sourcing Our Reactor Design, and the Future of Transatomic
mjewkes | 7 years ago | on: CEO Shoots Self to Test Bulletproof Jacket
The first bulletproof vest dates to the 1890s, and the inventor photographed tests on himself for publicity.
https://culture.pl/en/article/the-monk-who-stopped-bullets-w...
mjewkes | 7 years ago | on: Why Rust closures are somewhat hard
Lots of other problems are.
mjewkes | 7 years ago | on: When Cancer Was Conquerable
They absolutely are, all the time. Animal testing is relatively cheap (esp. for mice) and widespread in biotech. It's generally hard to get an IND approval (step 1 of human testing) without successful animal tests.
Animal models, unfortunately, aren't super effective at predicting human outcomes.